Trial site
Brookview Hills Research Associates, LLC
- 7running trials
- 7closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Chronic kidney disease10 trials
- Type 2 diabetes4 trials
- Obesity3 trials
- IgA nephropathy2 trials
- ANCA-associated vasculitis1 trial
- High blood pressure1 trial
- Phase
- Phase 37 trials
- Phase 26 trials
- Phase 41 trial
- Status
- Completed6 trials
- Active, not recruiting4 trials
- Recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Novo Nordisk A/S4 trials
- Boehringer Ingelheim3 trials
- Amgen2 trials
- Bayer1 trial
- Novartis Pharmaceuticals1 trial
- and 3 more
Running trials
Recruiting
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Active, not recruiting
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Recruiting
Active, not recruiting
Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- ANCA-associated vasculitis1 recruiting
- Chronic kidney disease1 recruiting
- IgA nephropathy1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Completed
A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease
Terminated
Completed
Completed
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
Site data: ClinicalTrials.govUpdated 14 Nov 2026